MARC

LEADER 00000cam a2200000 a 4500
001 b2473112
003 CoU
008 850401s1984 mdua b f100 0 eng d
035 |a ocm11896857 
035 |a (GPO)85019177 
040 |a HEW  |c HEW  |d GPO 
043 |a n-us--- 
049 |a COD9 
074 |a 507-G-2 
086 0 |a HE 20.3152:P 49/2 
086 0 |a HE 20.3152:P 49/2 
245 0 0 |a Minutes of the Phase I Working Group meeting and Biochemical Modulators Advisory Group meeting, July 9-10, 1984. 
260 |a Bethesda, Md. :  |b Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute,  |c 1984. 
300 |a ix, 401 pages :  |b illustrations ;  |c 28 cm. 
336 |a text  |b txt  |2 rdacontent. 
337 |a unmediated  |b n  |2 rdamedia. 
338 |a volume  |b nc  |2 rdacarrier. 
500 |a Cover title. 
504 |a Includes bibliographies. 
650 0 |a Cancer  |z United States  |x Chemotherapy  |v Congresses. 
710 2 |a National Cancer Institute (U.S.).  |b Cancer Therapy Evaluation Program.  |b Investigational Drug Branch.  |b Phase I Working Group.  |b Meeting.  |0 http://id.loc.gov/authorities/names/n85084824. 
710 2 |a National Cancer Institute (U.S.).  |b Cancer Therapy Evaluation Program.  |b Investigational Drug Branch.  |b Biochemical Modulators Advisory Group.  |b Meeting.  |0 http://id.loc.gov/authorities/names/n85084827. 
710 2 |a National Cancer Institute (U.S.).  |b Cancer Therapy Evaluation Program.  |b Investigational Drug Branch.  |0 http://id.loc.gov/authorities/names/n82237814. 
907 |a .b24731122  |b 03-18-20  |c 01-13-96 
998 |a gov  |b 03-21-95  |c -  |d m   |e -  |f eng  |g mdu  |h 0  |i 1 
907 |a .b24731122  |b 11-23-14  |c 01-13-96 
944 |a MARS - RDA ENRICHED 
907 |a .b24731122  |b 01-11-10  |c 01-13-96 
907 |a .b24731122  |b 01-13-96  |c 01-13-96 
999 f f |i afa3052e-dee9-5020-b755-6d13a1935a29  |s 5f882bb9-2222-5149-a4c5-0e506aa724a6 
952 f f |p Can circulate  |a University of Colorado Boulder  |b Boulder Campus  |c Norlin  |d Norlin Library - Government Information - US  |e HE 20.3152:P 49/2  |h Superintendent of Documents classification  |i document  |m U183049481528  |n 1